Hyperbaric Oxygen Therapy
Tracking # 20-829770
Course overview
Hyperbaric oxygen (HBO2) therapy is a treatment in which a patient breathes near 100% oxygen at a pressure above sea level (1 atmosphere absolute [ATA]) within a specially constructed hyperbaric chamber. HBO2 is currently approved by the U.S. Food and Drug Administration (FDA) as a primary and adjunctive treatment for a wide range of conditions. Multiple beneficial effects have been demonstrated in laboratory and animal studies: Hyperoxygenation, neovascularization, vasoconstriction, antimicrobial activity, and the prevention of inappropriate activation of leukocytes. This course will inform healthcare professionals about the availability and use of HBO2 and the implications for patients and healthcare providers.
Subject areas
This course counts toward the state boards and subject areas below.
Alabama State Board of Respiratory Therapy
Licensed Respiratory Therapist
Florida Board of Respiratory Care
Certified Respiratory Therapist
Registered Respiratory Therapist
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Georgia Composite Medical Board - Respiratory Care Professionals
Respiratory Care Professional
Louisiana State Board of Medical Examiners - Respiratory Therapy
Certified Respiratory Therapist
Licensed Respiratory Therapist
Registered Respiratory Therapist
MSDOH Bureau of Professional Licensure - Respiratory Care Practitioners
Respiratory Care Practitioner
Oklahoma Board of Medical Licensure and Supervision - Respiratory Care
Respiratory Care Practitioner
Disclosure statements
Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.